A
ANRO
Alto Neuroscienc
15.13
0.45+3.07%After Hours: 15.34 +0.21 +1.39%19:42 12/12 EST
OPEN/PREV CLOSE14.96/14.68
TODAY RANGE14.41-15.23
VOL217.79K
MARKET CAP470.03M
52 WEEK RANGE1.600-16.49
AVG VOL (3M)1.62M
% TURNOVER0.70%
TURNOVER--
P/E (TTM)-6.5617
% RANGE5.65%
EPS(TTM)-2.3058
P/E(FORWARD)-6.7394
P/B3.685
BVPS4.106
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP405.51M
SHARES OUTSTANDING31.07M
NEXT EARNINGS--
FREE FLOAT26.80M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·12/03 15:27
BTIG Keeps Their Buy Rating on Alto Neuroscience, Inc. (ANRO)
Seeking Alpha·11/28 17:38
Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026
TipRanks·11/28 11:05
Alto Neuroscience files to sell 8.45M shares of common stock for holders
TipRanks·11/18 14:25
Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies
Benzinga·11/17 16:39
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday
Benzinga·11/17 13:14
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Dow Jones·11/17 10:59
Alto Neuroscience Initiated at Buy by BTIG
Dow Jones·11/17 10:59
Alto Neuroscience Price Target Announced at $27.00/Share by BTIG
TipRanks·11/17 02:05
Stifel Nicolaus Keeps Their Buy Rating on Alto Neuroscience, Inc. (ANRO)
Dow Jones·11/13 12:46
Alto Neuroscience Is Maintained at Outperform by Baird
Benzinga·11/13 12:35
Baird Maintains Outperform on Alto Neuroscience, Raises Price Target to $22
TipRanks·11/13 12:06
Alto Neuroscience price target raised to $22 from $16 at Baird
Same Industry
Name/Symbol
Change%
Price